None
Quote | Five Prime Therapeutics Inc. (NASDAQ:FPRX)
Last: | $38 |
---|---|
Change Percent: | 0.03% |
Open: | $37.99 |
Close: | $38 |
High: | $38.01 |
Low: | $37.95 |
Volume: | 968,246 |
Last Trade Date Time: | 04/15/2021 04:56:59 pm |
News | Five Prime Therapeutics Inc. (NASDAQ:FPRX)
janiecbros/E+ via Getty Images Biotech M&A is poised to heat up again as shares of the SPDR S&P Biotech’s (XBI) have fallen about 25% from their February highs, according to Jefferies. Biotech deals may pick up after a 3-6 month of a large "drawdown" and as prices "normalize" f...
Merger activity increased last week with six new deals announced. $50 billion worth of deals announced in a single week. Thermo Fisher Scientific to acquire PPD Inc. For further details see: Merger Arbitrage Mondays - Microsoft's Acquisition Of Nuance Offers A 5% Spread ...
Message Board Posts | Five Prime Therapeutics Inc. (NASDAQ:FPRX)
Subject | By | Source | When |
---|---|---|---|
While its pulled back as expected from its | timberwolf7 | investorshub | 12/04/2020 8:47:28 PM |
Any troops on guard | howardriggin | investorshub | 11/20/2020 3:21:04 PM |
had a few more minutes to look into | timberwolf7 | investorshub | 11/17/2020 4:39:28 PM |
correct me if I am wrong, but they | timberwolf7 | investorshub | 11/13/2020 12:11:45 AM |
* * $FPRX Video Chart 11-12-2020 * * | ClayTrader | investorshub | 11/12/2020 10:40:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Five Prime Therapeutics Inc. Company Name:
FPRX Stock Symbol:
NASDAQ Market:
Five Prime Therapeutics Inc. Website:
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics PR Newswire THOUSAND OAKS, Calif. , April 16, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all out...
Amgen (NASDAQ: AMGN) recently announced plans to acquire Five Prime Therapeutics (NASDAQ: FPRX) for approximately $1.9 billion. The deal gives Amgen rights to bemarituzumab, which has made it through phase 2 testing. In this video from Motley Fool Live , recorded on ...
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) announced today that it has canceled its fourth quarter and full year 2020 earnings conference call, which was previously scheduled for Wednesday, March 10, 2021 at 1:30 p.m. PT / 4:30 p.m. ET. The cancellation is the result of the co...